154 related articles for article (PubMed ID: 31025168)
21. Surveillance of Low-Grade Appendiceal Mucinous Neoplasms With Peritoneal Metastases After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Are 5 Years Enough? A Multisite Experience.
Solomon D; Bekhor E; Leigh N; Maniar YM; Totin L; Hofstedt M; Aycart SN; Carr J; Ballentine S; Magge DR; Golas BJ; Pai RK; Polydorides AD; Bartlett DL; Labow DM; Choudry HA; Sarpel U
Ann Surg Oncol; 2020 Jan; 27(1):147-153. PubMed ID: 31385130
[TBL] [Abstract][Full Text] [Related]
22. Impact of ovarian metastases on survival in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancy originating from appendiceal and colorectal cancer.
Bignell MB; Mehta AM; Alves S; Chandrakumaran K; Dayal SP; Mohamed F; Cecil TD; Moran BJ
Colorectal Dis; 2018 Aug; 20(8):704-710. PubMed ID: 29502336
[TBL] [Abstract][Full Text] [Related]
23. ΔNp73 and its effector targets promote colorectal peritoneal carcinosis and predict survival.
Pastor-Morate D; Amigo-Morán L; Garranzo-Asensio M; Rejas-González R; Carnicero P; Rodríguez N; Pérez-Robledo JP; Barderas R; Prieto-Nieto I; Domínguez G
J Pathol; 2024 Jul; 263(3):328-337. PubMed ID: 38629257
[TBL] [Abstract][Full Text] [Related]
24. Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma.
Piso P; Bektas H; Werner U; Schlitt HJ; Kubicka S; Bornscheuer A; Manns M; Klempnauer J
Eur J Surg Oncol; 2001 Apr; 27(3):286-90. PubMed ID: 11373107
[TBL] [Abstract][Full Text] [Related]
25. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin.
Delhorme JB; Severac F; Averous G; Glehen O; Passot G; Bakrin N; Marchal F; Pocard M; Lo Dico R; Eveno C; Carrere S; Sgarbura O; Quenet F; Ferron G; Goéré D; Brigand C;
Br J Surg; 2018 May; 105(6):668-676. PubMed ID: 29412465
[TBL] [Abstract][Full Text] [Related]
26. Repeat cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal carcinomatosis of appendiceal origin.
Kitai T; Yamanaka K
Int J Clin Oncol; 2018 Apr; 23(2):298-304. PubMed ID: 29181652
[TBL] [Abstract][Full Text] [Related]
27. Goblet cell carcinoid of the vermiform appendix with ovarian metastasis mimicking mucinous cystadenocarcinoma.
Ikeda E; Tsutsumi Y; Yoshida H; Yanagi K
Acta Pathol Jpn; 1991 Jun; 41(6):455-60. PubMed ID: 1950561
[TBL] [Abstract][Full Text] [Related]
28. A Prognostic Model for Predicting Overall Survival in Patients with Peritoneal Surface Malignancy of an Appendiceal Origin Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Ihemelandu C; Fernandez S; Sugarbaker PH
Ann Surg Oncol; 2017 Aug; 24(8):2266-2272. PubMed ID: 28342015
[TBL] [Abstract][Full Text] [Related]
29. Mucinous tumors of the vermiform appendix and ovary, and pseudomyxoma peritonei: histogenetic implications of cytokeratin 7 expression.
Guerrieri C; Frånlund B; Fristedt S; Gillooley JF; Boeryd B
Hum Pathol; 1997 Sep; 28(9):1039-45. PubMed ID: 9308728
[TBL] [Abstract][Full Text] [Related]
30. Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience.
Feferman Y; Solomon D; Bhagwandin S; Kim J; Aycart SN; Feingold D; Sarpel U; Labow DM
Ann Surg Oncol; 2019 Feb; 26(2):482-489. PubMed ID: 30539491
[TBL] [Abstract][Full Text] [Related]
31. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT
Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622
[TBL] [Abstract][Full Text] [Related]
32. The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas: a clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites.
Ronnett BM; Kurman RJ; Shmookler BM; Sugarbaker PH; Young RH
Am J Surg Pathol; 1997 Oct; 21(10):1144-55. PubMed ID: 9331286
[TBL] [Abstract][Full Text] [Related]
33. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Jimenez W; Sardi A; Nieroda C; Sittig M; Milovanov V; Nunez M; Aydin N; Gushchin V
Ann Surg Oncol; 2014 Dec; 21(13):4218-25. PubMed ID: 24986239
[TBL] [Abstract][Full Text] [Related]
34. Toxicity profile of chemotherapy agents used in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies.
Somashekhar SP; Yethadka R; Kumar C R; Ashwin KR; Zaveri S; Rauthan A
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):577-581. PubMed ID: 31677939
[TBL] [Abstract][Full Text] [Related]
35. Ovarian metastases of appendiceal tumors with goblet cell carcinoidlike and signet ring cell patterns: a report of 30 cases.
Hristov AC; Young RH; Vang R; Yemelyanova AV; Seidman JD; Ronnett BM
Am J Surg Pathol; 2007 Oct; 31(10):1502-11. PubMed ID: 17895750
[TBL] [Abstract][Full Text] [Related]
36. Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy.
Stewart JH; Shen P; Russell GB; Bradley RF; Hundley JC; Loggie BL; Geisinger KR; Levine EA
Ann Surg Oncol; 2006 May; 13(5):624-34. PubMed ID: 16538401
[TBL] [Abstract][Full Text] [Related]
37. A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendix.
Elias D; Glehen O; Pocard M; Quenet F; Goéré D; Arvieux C; Rat P; Gilly F;
Ann Surg; 2010 May; 251(5):896-901. PubMed ID: 20395843
[TBL] [Abstract][Full Text] [Related]
38. Adverse Events Postoperatively Had No Impact on Long-Term Survival of Patients Treated with Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Appendiceal Cancer with Peritoneal Metastases.
Ihemelandu C; Mavros MN; Sugarbaker P
Ann Surg Oncol; 2016 Dec; 23(13):4231-4237. PubMed ID: 27338748
[TBL] [Abstract][Full Text] [Related]
39. Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal Pseudomyxoma Peritonei: Analysis of 519 patients.
Taflampas P; Dayal S; Chandrakumaran K; Mohamed F; Cecil TD; Moran BJ
Eur J Surg Oncol; 2014 May; 40(5):515-520. PubMed ID: 24462284
[TBL] [Abstract][Full Text] [Related]
40. Adenocarcinoma of the appendix with extra-appendicular spread: Clinico-surgical and histologic analysis of 27 cases.
Morera Ocón FJ; Camps Vilata B; Muñoz Forner E; Navarro Campoy C; Gallego Plazas J; Navarro Fos S
Med Clin (Barc); 2017 Aug; 149(4):153-156. PubMed ID: 28549831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
